International hypoglycaemia study group and Campbell, Matthew (2017) Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care, 40 (1). pp. 155-157. ISSN 1935-5548
Document
-
13136.pdf - Published Version
Available under License Creative Commons Attribution.
Abstract
Abstract
Position Statement
The International Hypoglycaemia Study Group recommends that the frequency of detection of a glucose concentration <3.0 mmol/l (<54 mg/dl), which it considers to be clinically significant biochemical hypoglycaemia, be included in reports of clinical trials of glucose-lowering drugs evaluated for the treatment of diabetes mellitus.
| Item Type: | Article |
|---|---|
| Depositing User: | Matthew Campbell |
| URI: | https://sure.sunderland.ac.uk/id/eprint/13136 |
Further Details
More Information
Identifiers
Users with ORCIDS
Catalogue record
Contributors
University Divisions
Actions (login required)
Dimensions
DimensionsDownload Statistics
Downloads per month over past year